Crossmark

CRISPR/Cas9 gene editing clarifies the role of CD33 SNP rs12459419 in gemtuzumab ozogamicin-mediated cytotoxicity

Published Online: 2024-06-10

Published Print: 2024-08

Authors

Oya, Shuki

Ozawa, Hidetoshi

Nakamura, Takayuki

Mori, Akira

Ochi, Sorahiko

Maehiro, Yoshimi

Umeda, Masahiro

Takaki, Yusuke

Fukuyama, Toshinobu

Yamasaki, Yoshitaka

Yamaguchi, Maki

Aoyama, Kazutoshi

Mouri, Fumihiko

Nagafuji, Koji https://orcid.org/0000-0003-4795-121X
License Information

Text and Data Mining valid from 2024-06-10

Version of Record valid from 2024-06-10
More Information

Article History

Received: 22 February 2024

Revised: 27 May 2024

Accepted: 28 May 2024

First Online: 10 June 2024

Document is current